Welcome to our dedicated page for Nutanix SEC filings (Ticker: NTNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nutanix, Inc. (NASDAQ: NTNX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Nutanix is a hybrid multicloud software company, and its filings offer detailed insight into how it describes its cloud platform, subscription business model, governance practices, and capital allocation decisions.
Investors can review Form 10-K annual reports and Form 10-Q quarterly reports for management’s discussion of Nutanix’s hybrid multicloud strategy, its Nutanix Cloud Platform and related offerings, and key risk factors. Current reports on Form 8-K document specific material events, such as the announcement of accelerated share repurchase agreements, updates to equity incentive plans, executive and director compensation decisions, quarterly and annual financial results, and board appointments.
This page also surfaces proxy materials such as the DEF 14A definitive proxy statement, where Nutanix discusses topics including its evolution into a broader cloud platform company, its vision for running applications and AI and managing data anywhere, and proposals related to director elections, auditor ratification, advisory votes on executive compensation, and equity plan amendments.
Stock Titan enhances these NTNX filings with AI-powered summaries that explain the contents of lengthy documents in accessible language. Users can quickly understand the significance of complex items in 10-Ks and 10-Qs, follow executive and director compensation arrangements described in proxy statements and 8-Ks, and track ongoing capital return programs and other corporate actions disclosed in current reports. Real-time updates from EDGAR ensure that new Nutanix filings, including any Form 4 insider transaction reports or additional 8-Ks, appear promptly with AI-generated context.
Nutanix, Inc. disclosed that it completed a private sale of equity to raise new cash. On May 4, 2026, the company issued and sold 4,136,789 shares of its Class A common stock to Advanced Micro Devices, Inc. (AMD) at $36.26 per share, for an aggregate cash purchase price of approximately $150 million.
The transaction was completed under a Stock Purchase Agreement dated February 23, 2026 and was structured as a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
Nutanix Inc disclosed that Vanguard Capital Management beneficially owned 14,131,782 shares of Common Stock, representing 5.32% of the class. The filing states Vanguard has sole dispositive power over 14,131,782 shares and sole voting power over 2,051,457 shares.
The statement explains the holding reflects securities managed across Vanguard business divisions and funds; the signer is Ashley Grim, dated 04/30/2026.
Nutanix Inc ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 14,066,977 shares of Nutanix common stock, representing 5.3% of the class as of 03/31/2026. The filing states Vanguard has sole power to dispose of 14,066,977 shares and sole voting power for 57,752 shares. The Schedule 13G identifies Vanguard Portfolio Management and affiliated voting/dispositive arrangements and is signed on 04/29/2026.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix ownership disclosure: The Vanguard Group filed an Amendment No. 10 to its Schedule 13G/A reporting 0 shares beneficially owned of Nutanix common stock, equal to 0%. The filing explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report separately. The amendment is signed by Ashley Grim on March 27, 2026.
Nutanix, Inc. filed an update explaining that its Board of Directors has adopted Second Amended and Restated Bylaws, effective immediately on March 24, 2026. The revisions refine advance notice procedures for stockholder director nominations and other business, clarifying timing, disclosure details, and related procedures.
The changes also clarify the authority of the Board and the chairperson to set rules and procedures at stockholder meetings. In addition, the bylaws update indemnification provisions to define which officers are entitled to mandatory indemnification and expense advancement, along with other modernizing and administrative clarifications.
Nutanix, Inc. Chief Executive Officer Rajiv Ramaswami reported the vesting and settlement of restricted stock units into 50,429 shares of Class A common stock on March 15, 2026. To cover related tax obligations, 23,428 shares were withheld by Nutanix at $39.29 per share, leaving him with 574,879 shares directly held.
Nutanix, Inc. President and CCO Tarkan Maner exercised restricted stock units that converted into 11,041 shares of Class A common stock on March 15, 2026. These RSUs carried a zero exercise price and represent routine equity compensation vesting. Of the acquired shares, 4,093 were withheld by Nutanix to cover tax obligations, as noted in the footnotes, leaving Maner with 103,993 shares of Class A common stock held directly after the transactions. Each RSU represents a right to receive one share of Class A common stock, and the RSU grants vest in 16 equal quarterly installments, subject to his continued service.
Nutanix, Inc. Chief Legal Officer Brian Martin reported the vesting and settlement of Restricted Stock Units, or RSUs. He exercised RSUs covering 4,727 shares, receiving the same number of Class A common shares at a price of $0.00 per share.
To cover tax withholding obligations from this vesting, 1,819 shares of Class A common stock were withheld by the company at $39.29 per share. After these transactions, Martin directly holds 10,398 shares of Nutanix Class A common stock. The RSUs vest over time in quarterly installments, subject to his continued service.
Nutanix, Inc. Chief Financial Officer Rukmini Sivaraman reported the vesting of multiple Restricted Stock Unit awards on March 15, 2026, exercising derivative awards into 22,150 shares of Class A common stock at an exercise price of $0.00 per share. To satisfy tax withholding obligations from these RSU vestings, the issuer withheld 8,064 shares at a price of $39.29 per share instead of taking cash. After these compensation-related transactions, Sivaraman directly holds 279,622 shares of Nutanix Class A common stock. Footnotes explain that each RSU represents one share and that the RSU grants vest in 16 equal quarterly installments starting on dates ranging from September 15, 2022 through December 15, 2025, contingent on continued service.